These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 30719536)

  • 41. Genotype prediction of ATRX mutation in lower-grade gliomas using an MRI radiomics signature.
    Li Y; Liu X; Qian Z; Sun Z; Xu K; Wang K; Fan X; Zhang Z; Li S; Wang Y; Jiang T
    Eur Radiol; 2018 Jul; 28(7):2960-2968. PubMed ID: 29404769
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Residual Convolutional Neural Network for the Determination of
    Chang K; Bai HX; Zhou H; Su C; Bi WL; Agbodza E; Kavouridis VK; Senders JT; Boaro A; Beers A; Zhang B; Capellini A; Liao W; Shen Q; Li X; Xiao B; Cryan J; Ramkissoon S; Ramkissoon L; Ligon K; Wen PY; Bindra RS; Woo J; Arnaout O; Gerstner ER; Zhang PJ; Rosen BR; Yang L; Huang RY; Kalpathy-Cramer J
    Clin Cancer Res; 2018 Mar; 24(5):1073-1081. PubMed ID: 29167275
    [No Abstract]   [Full Text] [Related]  

  • 43. Automated machine learning based on radiomics features predicts H3 K27M mutation in midline gliomas of the brain.
    Su X; Chen N; Sun H; Liu Y; Yang X; Wang W; Zhang S; Tan Q; Su J; Gong Q; Yue Q
    Neuro Oncol; 2020 Mar; 22(3):393-401. PubMed ID: 31563963
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MRI Features May Predict Molecular Features of Glioblastoma in
    Park CJ; Han K; Kim H; Ahn SS; Choi D; Park YW; Chang JH; Kim SH; Cha S; Lee SK
    AJNR Am J Neuroradiol; 2021 Mar; 42(3):448-456. PubMed ID: 33509914
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radiomics risk score may be a potential imaging biomarker for predicting survival in isocitrate dehydrogenase wild-type lower-grade gliomas.
    Park CJ; Han K; Kim H; Ahn SS; Choi YS; Park YW; Chang JH; Kim SH; Jain R; Lee SK
    Eur Radiol; 2020 Dec; 30(12):6464-6474. PubMed ID: 32740813
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Machine Learning for the Prediction of Molecular Markers in Glioma on Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis.
    Jian A; Jang K; Manuguerra M; Liu S; Magnussen J; Di Ieva A
    Neurosurgery; 2021 Jun; 89(1):31-44. PubMed ID: 33826716
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A radiomics model based on DCE-MRI and DWI may improve the prediction of estimating IDH1 mutation and angiogenesis in gliomas.
    Wang J; Hu Y; Zhou X; Bao S; Chen Y; Ge M; Jia Z
    Eur J Radiol; 2022 Feb; 147():110141. PubMed ID: 34995947
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An Intra- and Inter-Modality Fusion Model Using MR Images for Prediction of Glioma Isocitrate Dehydrogenase (IDH) Mutation.
    Shi X; Zhang X; Iwamoto Y; Cheng J; Bai J; Zhao G; Chen YW
    Annu Int Conf IEEE Eng Med Biol Soc; 2022 Jul; 2022():198-202. PubMed ID: 36086447
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radiogenomics of lower-grade gliomas: machine learning-based MRI texture analysis for predicting 1p/19q codeletion status.
    Kocak B; Durmaz ES; Ates E; Sel I; Turgut Gunes S; Kaya OK; Zeynalova A; Kilickesmez O
    Eur Radiol; 2020 Feb; 30(2):877-886. PubMed ID: 31691122
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Visualization of tumor heterogeneity and prediction of isocitrate dehydrogenase mutation status for human gliomas using multiparametric physiologic and metabolic MRI.
    Hagiwara A; Tatekawa H; Yao J; Raymond C; Everson R; Patel K; Mareninov S; Yong WH; Salamon N; Pope WB; Nghiemphu PL; Liau LM; Cloughesy TF; Ellingson BM
    Sci Rep; 2022 Jan; 12(1):1078. PubMed ID: 35058510
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Whole brain morphologic features improve the predictive accuracy of IDH status and VEGF expression levels in gliomas.
    Zhang S; Chen D; Sun H; Kemp GJ; Chen Y; Tan Q; Yang Y; Gong Q; Yue Q
    Cereb Cortex; 2024 Apr; 34(4):. PubMed ID: 38642107
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lesion location implemented magnetic resonance imaging radiomics for predicting IDH and TERT promoter mutations in grade II/III gliomas.
    Arita H; Kinoshita M; Kawaguchi A; Takahashi M; Narita Y; Terakawa Y; Tsuyuguchi N; Okita Y; Nonaka M; Moriuchi S; Takagaki M; Fujimoto Y; Fukai J; Izumoto S; Ishibashi K; Nakajima Y; Shofuda T; Kanematsu D; Yoshioka E; Kodama Y; Mano M; Mori K; Ichimura K; Kanemura Y
    Sci Rep; 2018 Aug; 8(1):11773. PubMed ID: 30082856
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prediction of IDH1 Mutation Status in Glioblastoma Using Machine Learning Technique Based on Quantitative Radiomic Data.
    Lee MH; Kim J; Kim ST; Shin HM; You HJ; Choi JW; Seol HJ; Nam DH; Lee JI; Kong DS
    World Neurosurg; 2019 May; 125():e688-e696. PubMed ID: 30735871
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diffusion tensor image features predict IDH genotype in newly diagnosed WHO grade II/III gliomas.
    Eichinger P; Alberts E; Delbridge C; Trebeschi S; Valentinitsch A; Bette S; Huber T; Gempt J; Meyer B; Schlegel J; Zimmer C; Kirschke JS; Menze BH; Wiestler B
    Sci Rep; 2017 Oct; 7(1):13396. PubMed ID: 29042619
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MRI features predict p53 status in lower-grade gliomas via a machine-learning approach.
    Li Y; Qian Z; Xu K; Wang K; Fan X; Li S; Jiang T; Liu X; Wang Y
    Neuroimage Clin; 2018; 17():306-311. PubMed ID: 29527478
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A multimodal domain adaptive segmentation framework for IDH genotype prediction.
    Zeng H; Xing Z; Gao F; Wu Z; Huang W; Su Y; Chen Z; Cai S; Cao D; Cai C
    Int J Comput Assist Radiol Surg; 2022 Oct; 17(10):1923-1931. PubMed ID: 35794409
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Noninvasively evaluating the grading and IDH1 mutation status of diffuse gliomas by three-dimensional pseudo-continuous arterial spin labeling and diffusion-weighted imaging.
    Liu T; Cheng G; Kang X; Xi Y; Zhu Y; Wang K; Sun C; Ye J; Li P; Yin H
    Neuroradiology; 2018 Jul; 60(7):693-702. PubMed ID: 29777252
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predicting IDH genotype in gliomas using FET PET radiomics.
    Lohmann P; Lerche C; Bauer EK; Steger J; Stoffels G; Blau T; Dunkl V; Kocher M; Viswanathan S; Filss CP; Stegmayr C; Ruge MI; Neumaier B; Shah NJ; Fink GR; Langen KJ; Galldiks N
    Sci Rep; 2018 Sep; 8(1):13328. PubMed ID: 30190592
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prediction of IDH mutation status of glioma based on terahertz spectral data.
    Sun Z; Wu X; Tao R; Zhang T; Liu X; Wang J; Wan H; Zheng S; Zhao X; Zhang Z; Yang P
    Spectrochim Acta A Mol Biomol Spectrosc; 2023 Jul; 295():122629. PubMed ID: 36958244
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel fully automated MRI-based deep-learning method for classification of IDH mutation status in brain gliomas.
    Bangalore Yogananda CG; Shah BR; Vejdani-Jahromi M; Nalawade SS; Murugesan GK; Yu FF; Pinho MC; Wagner BC; Mickey B; Patel TR; Fei B; Madhuranthakam AJ; Maldjian JA
    Neuro Oncol; 2020 Mar; 22(3):402-411. PubMed ID: 31637430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.